$TRU

TransUnion signals 8%-9% organic constant currency revenue growth in 2026 while planning ~$500M buybacks (NYSE:TRU)

TransUnion (TRU) reported Q3 2026 revenue, adjusted EBITDA, and adjusted diluted earnings per share above guidance. The company expects 8%-9% organic constant currency revenue growth for 2026 and plans $500M in share buybacks. According to CEO Christopher Cartwright, growth was broad-based.

Original reporting
Published Oct 27, 2026, 6:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 6:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$TRU
Bullish
high confidence
Mentioned
$TRU
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$TRUBullishHigh
01

Why it matters

The new guidance and buyback are likely to be incorporated into analyst models, prompting short‑term buying.

02

Market read

Fresh guidance and buyback make the story highly relevant for traders focused on earnings and capital‑return events.

03

What to watch

Potential macro‑economic headwinds could temper the impact of the guidance.

Relevance 8/10Novelty 8/10Timing: after‑hours

Background

TransUnion's earnings call provided the latest guidance and capital‑return plan.

Company-level read

Ticker impact

$TRUBullishHigh confidence
Context

TransUnion disclosed 8%-9% organic constant‑currency revenue growth for 2026 and announced a $500M share‑buyback program.

Expected impact

upward pressure as investors price in higher growth and buyback support

Evidence & confidence

Both the growth guidance and the buyback are fresh primary disclosures that can move the share price in the near term.

Market effects

Positive outlook may lift other credit‑reporting and data‑analytics firms.

U.S. market participants may see a modest boost in consumer‑finance related stocks.

Limited to U.S. equities; no direct global macro effect.

Counterpoint

If growth guidance is already priced in, the buyback may not add further upside.

Key entities

  • TransUnion

    U.S. credit‑reporting and analytics firm.

Related articles

$TRUHighAI 8/10

TransUnion (TRU) (Q3 2026) Earnings Call Highlights: Revenue and EPS Beat Guidance

TransUnion (TRU) reported Q3 2026 earnings beating guidance with 8% revenue growth and 14% EPS growth. International business grew 10%, led by India and Latin America. The company reduced its leverage ratio and increased share repurchase authorization. However, rising interest rates are expected to slow mortgage volumes and auto affordability, leading to a sequential deceleration in revenue growth to 3-6% in Q4. Legal and regulatory expenses also contributed to margin contraction.

$TRUHighAI 8/10

TransUnion (TRU) Q3 2026 Earnings Call Transcript

TransUnion (TRU) reported Q3 2026 organic revenue growth of 8%, with adjusted EPS up 14%. U.S. Markets revenue rose 7%, while international revenue grew 10%, led by India and Latin America. The company repurchased $126M in shares and raised its repurchase authorization by $1B. Despite economic uncertainties, TRU raised its full-year guidance, expecting 8-9% revenue growth and 12-13% adjusted EPS growth.

$TRUMed

TransUnion Q3 2026 Earnings Call Summary

TransUnion reported Q3 2026 earnings, highlighting 18% growth in India and Latin America, 13% auto growth, and 10% international growth. The company expects full-year share repurchases of $500M and plans to expand its OneTru platform globally. Management noted resilience in US Financial Services despite inflation and higher interest rates, and provided guidance for Q4, including potential impacts from regulatory changes and market softening.

$TRUHighAI 8/10

TransUnion Q3 2026 slides: insurance drives growth amid margin pressure

TransUnion (TRU) reported Q3 2026 earnings with revenue of $1.31B, matching estimates, and EPS of $1.25, beating forecasts. Revenue grew 8% organically, driven by insurance and international markets. However, adjusted EBITDA margin contracted by 90 basis points to 35.4%. The company raised full-year guidance, expecting 8-9% revenue growth and 12-13% EPS growth. Shares fell 2.19% in premarket trading.